ryanodine and Epilepsy

ryanodine has been researched along with Epilepsy* in 2 studies

Reviews

1 review(s) available for ryanodine and Epilepsy

ArticleYear
[Calcium channels and human genetic diseases].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2004, Volume: 42, Issue:7

    Topics: Ataxia; Calcium Channels; Epilepsy; Genetic Diseases, Inborn; Humans; Hypokalemic Periodic Paralysis; Malignant Hyperthermia; Migraine with Aura; Myopathy, Central Core; Ryanodine; Spinocerebellar Ataxias

2004

Other Studies

1 other study(ies) available for ryanodine and Epilepsy

ArticleYear
NMDA receptor-mediated epileptiform persistent activity requires calcium release from intracellular stores in prefrontal neurons.
    Experimental neurology, 2006, Volume: 197, Issue:2

    Various normal and pathological forms of synchronized population activity are generated by recurrent excitation among pyramidal neurons in the neocortex. However, the intracellular signaling mechanisms underlying this activity remain poorly understood. In this study, we have examined the cellular properties of synchronized epileptiform activity in the prefrontal cortex with particular emphasis on a potential role of intracellular calcium stores. We find that the zero-magnesium-induced synchronized activity is blocked by inhibition of sarco-endoplasmic reticulum Ca(2+)-ATPases, phospholipase C (PLC), the inositol 1,4,5-trisphosphate (IP3) receptor, and the ryanodine receptor. This same activity is, however, not affected by application of metabotropic glutamatergic receptor (mGluR) agonists, nor by introduction of an mGluR antagonist. These results suggest that persistent synchronized activity in vitro is dependent upon calcium release from internal calcium stores through the activation of PLC-IP3 receptor pathway. Our findings also raise the possibility that intracellular calcium release may be involved in the generation of pathologic synchronized activity in epilepsy in vivo and in physiological forms of synchronized cortical activity.

    Topics: Action Potentials; Animals; Calcium; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Epilepsy; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Ferrets; In Vitro Techniques; Intracellular Space; Magnesium; Neurons; Patch-Clamp Techniques; Prefrontal Cortex; Receptors, N-Methyl-D-Aspartate; Ryanodine

2006